Literature DB >> 10613852

Genetic plasticity of V genes under somatic hypermutation: statistical analyses using a new resampling-based methodology.

M Oprea1, T B Kepler.   

Abstract

Evidence for somatic hypermutation of immunoglobulin genes has been observed in all of the species in which immunoglobulins have been found. Previous studies have suggested that codon usage in immunoglobulin variable (V) region genes is such that the sequence-specificity of somatic hypermutation results in greater mutability in complementarity-determining regions of the gene than in the framework regions. We have developed a new resampling-based methodology to explore genetic plasticity in individual V genes and in V gene families in a statistically meaningful way. We determine what factors contribute to this mutability difference and characterize the strength of selection for this effect. We find that although the codon usage in immunoglobulin V genes renders them distinct among translationally equivalent sequences with random codon usage, they are nevertheless not optimal in this regard. We find that the mutability patterns in a number of species are similar to those we find for human sequences. Interestingly, sheep sequences show extremely strong mutability differences, consistent with the role of somatic hypermutation in the diversification of primary antibody repertoire in these animals. Human TCR V(beta) sequences resemble immunoglobulin in mutability pattern, suggesting one of several alternatives, that hypermutation is functionally operating in TCR, that it was once operating in TCR or in the common precursor of TCR and immunoglobulin, or that the hypermutation mechanism has evolved to exploit the codon usage in immunoglobulin (and fortuitously, TCR) rather than vice-versa. Our findings provide support to the hypothesis that somatic hypermutation appeared very early in the phylogeny of immune systems, that it is, to a large extent, shared between species, and that it makes an essential contribution to the generation of the antibody repertoire.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10613852      PMCID: PMC310983          DOI: 10.1101/gr.9.12.1294

Source DB:  PubMed          Journal:  Genome Res        ISSN: 1088-9051            Impact factor:   9.043


  35 in total

1.  AN AUTORADIOGRAPHIC STUDY OF THE GERMINAL CENTER IN SPLEEN WHITE PULP DURING EARLY INTERVALS OF THE IMMUNE RESPONSE.

Authors:  M G HANNA
Journal:  Lab Invest       Date:  1964-02       Impact factor: 5.662

Review 2.  The molecular and cellular basis of affinity maturation in the antibody response.

Authors:  G J Nossal
Journal:  Cell       Date:  1992-01-10       Impact factor: 41.582

3.  Boundaries of somatic mutation in rearranged immunoglobulin genes: 5' boundary is near the promoter, and 3' boundary is approximately 1 kb from V(D)J gene.

Authors:  S G Lebecque; P J Gearhart
Journal:  J Exp Med       Date:  1990-12-01       Impact factor: 14.307

4.  Sites of specific B cell activation in primary and secondary responses to T cell-dependent and T cell-independent antigens.

Authors:  Y J Liu; J Zhang; P J Lane; E Y Chan; I C MacLennan
Journal:  Eur J Immunol       Date:  1991-12       Impact factor: 5.532

5.  Intraclonal generation of antibody mutants in germinal centres.

Authors:  J Jacob; G Kelsoe; K Rajewsky; U Weiss
Journal:  Nature       Date:  1991-12-05       Impact factor: 49.962

6.  Positive darwinian selection observed at the variable-region genes of immunoglobulins.

Authors:  T Tanaka; M Nei
Journal:  Mol Biol Evol       Date:  1989-09       Impact factor: 16.240

Review 7.  Somatic generation of antibody diversity.

Authors:  S Tonegawa
Journal:  Nature       Date:  1983-04-14       Impact factor: 49.962

8.  Maturation of the immune response in germinal centers.

Authors:  C Berek; A Berger; M Apel
Journal:  Cell       Date:  1991-12-20       Impact factor: 41.582

9.  Somatic mutation in constant regions of mouse lambda 1 light chains.

Authors:  N Motoyama; H Okada; T Azuma
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-15       Impact factor: 11.205

10.  In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. II. A common clonal origin for periarteriolar lymphoid sheath-associated foci and germinal centers.

Authors:  J Jacob; G Kelsoe
Journal:  J Exp Med       Date:  1992-09-01       Impact factor: 14.307

View more
  7 in total

1.  Differences in potential for amino acid change after mutation reveals distinct strategies for kappa and lambda light-chain variation.

Authors:  Uri Hershberg; Mark J Shlomchik
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-12       Impact factor: 11.205

2.  Ancient phylogenetic beginnings of immunoglobulin hypermutation.

Authors:  Jaroslav Kubrycht; Karel Sigler; Michal Růzicka; Pavel Soucek; Jirí Borecký; Petr Jezek
Journal:  J Mol Evol       Date:  2006-10-06       Impact factor: 2.395

3.  B cell variable genes have evolved their codon usage to focus the targeted patterns of somatic mutation on the complementarity determining regions.

Authors:  Jasmine Saini; Uri Hershberg
Journal:  Mol Immunol       Date:  2015-02-06       Impact factor: 4.407

4.  Intricate targeting of immunoglobulin somatic hypermutation maximizes the efficiency of affinity maturation.

Authors:  Nai-Ying Zheng; Kenneth Wilson; Matthew Jared; Patrick C Wilson
Journal:  J Exp Med       Date:  2005-05-02       Impact factor: 14.307

5.  Selection and Neutral Mutations Drive Pervasive Mutability Losses in Long-Lived Anti-HIV B-Cell Lineages.

Authors:  Marcos C Vieira; Daniel Zinder; Sarah Cobey
Journal:  Mol Biol Evol       Date:  2018-05-01       Impact factor: 16.240

Review 6.  Beyond Hot Spots: Biases in Antibody Somatic Hypermutation and Implications for Vaccine Design.

Authors:  Chaim A Schramm; Daniel C Douek
Journal:  Front Immunol       Date:  2018-08-14       Impact factor: 7.561

7.  Altering the spectrum of immunoglobulin V gene somatic hypermutation by modifying the active site of AID.

Authors:  Meng Wang; Cristina Rada; Michael S Neuberger
Journal:  J Exp Med       Date:  2010-01-04       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.